APA (7th ed.) Citation

Knetki-Wróblewska, M., Kowalski, D., Czyżewicz, G., Bryl, M., Wrona, A., Dziadziuszko, R., . . . Krzakowski, M. (2020). Effectiveness of Osimertinib in Patients with Lung Adenocarcinoma in Clinical Practice—The Expanded Drug Access Program in Poland. Advances in respiratory medicine, 88(3), 189-196. https://doi.org/10.5603/ARM.2020.0130

Chicago Style (17th ed.) Citation

Knetki-Wróblewska, Magdalena, et al. "Effectiveness of Osimertinib in Patients with Lung Adenocarcinoma in Clinical Practice—The Expanded Drug Access Program in Poland." Advances in Respiratory Medicine 88, no. 3 (2020): 189-196. https://doi.org/10.5603/ARM.2020.0130.

MLA (9th ed.) Citation

Knetki-Wróblewska, Magdalena, et al. "Effectiveness of Osimertinib in Patients with Lung Adenocarcinoma in Clinical Practice—The Expanded Drug Access Program in Poland." Advances in Respiratory Medicine, vol. 88, no. 3, 2020, pp. 189-196, https://doi.org/10.5603/ARM.2020.0130.